Journal of Tuberculosis and Lung Disease ›› 2020, Vol. 1 ›› Issue (1): 39-44.doi: 10.3969/j.issn.2096-8493.2020.01.009
• Original Articles • Previous Articles Next Articles
WANG Chun-ting, LI Ya-qi, MI Yan, MO Nian-chun, LIU Hong-yan, LE Xing, ZHOU Li, WU Bi-feng, HAN Shi-yun, BAI Li-qiong(), ZHANG Chuan-fang
Received:
2020-02-10
Online:
2020-06-30
Published:
2020-07-07
Contact:
BAI Li-qiong
E-mail:382818713@qq.com
WANG Chun-ting, LI Ya-qi, MI Yan, MO Nian-chun, LIU Hong-yan, LE Xing, ZHOU Li, WU Bi-feng, HAN Shi-yun, BAI Li-qiong, ZHANG Chuan-fang. Monitoring of pulmonary function in patients with active tuberculosis during anti-tuberculosis treatment[J]. Journal of Tuberculosis and Lung Disease , 2020, 1(1): 39-44. doi: 10.3969/j.issn.2096-8493.2020.01.009
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.jtbld.cn/EN/10.3969/j.issn.2096-8493.2020.01.009
疗程 | 总体状态评估异常 | 肺通气功能异常 | 弥散功能异常 | 肺容积异常 | 呼吸总阻抗异常 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
例数 | 异常率(%) | 例数 | 异常率(%) | 例数 | 异常率(%) | 例数 | 异常率(%) | 例数 | 异常率(%) | |||||
治疗前 | 229 | 91.97 | 167 | 67.07 | 120 | 48.19 | 179 | 71.89 | 85 | 34.14 | ||||
1个月末 | 216 | 86.75 | 154 | 61.85 | 107 | 42.97 | 154 | 61.85 | 83 | 33.33 | ||||
强化期末 | 208 | 83.53 | 146 | 58.63 | 103 | 41.37 | 130 | 52.21 | 59 | 23.69 | ||||
疗程末 | 192 | 77.11 | 129 | 51.81 | 75 | 30.12 | 110 | 44.18 | 59 | 23.69 | ||||
25.434 | 25.255 | 37.227 | 60.238 | 27.153 | ||||||||||
P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
疗程 | FVC (%, | FEV1 [%, M(Q1, Q3)] | FEV1/FVC [%, M(Q1, Q3)] | TLC (%, | RV [%, M(Q1, Q3)] | RV/TLC [%, M(Q1, Q3)] | DLCO (%, | Z5 [%, M(Q1, Q3)] | R5 [%, M(Q1, Q3)] | R20 [%, M(Q1, Q3)] |
---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 83.29± 19.19 | 79.08 (64.85, 92.00) | 94.95 (86.51, 102.66) | 81.17± 15.26 | 95.50 (80.10, 115.35) | 119.18 (101.49, 137.65) | 80.28± 17.21 | 126.00 (109.50, 149.50) | 118.00 (102.50, 141.00) | 129.00 (111.50, 149.50) |
1个月末 | 86.67± 17.84a | 84.00 (70.50, 94.00)b | 95.50 (87.10, 103.26) | 83.91± 14.81a | 95.20 (82.03, 110.30) | 114.11 (100.62, 130.40) | 83.05± 17.01a | 118.00 (103.00, 145.00)b | 112.00 (95.00, 135.50)b | 126.00 (106.00, 142.50)b |
强化期末 | 89.15± 17.01c,d | 86.00 (75.00, 95.00)e,f | 95.55 (87.81, 102.98) | 85.65± 12.93c,d | 95.40 (83.15, 112.45) | 112.20 (98.68, 126.41) | 84.83± 16.35c,d | 117.00 (103.00, 140.00)e | 108.00 (95.00, 132.50)e | 123.00 (106.50, 141.00)e |
疗程末 | 92.69± 16.41g,h,i | 89.00 (78.65, 98.89)j,k,l | 95.49 (87.13, 102.37) | 88.83± 12.98g,h,i | 94.40 (81.60, 108.96)k,l | 106.56 (94.71, 122.22)j,k,l | 89.44± 16.97g,h,i | 114.00 (97.00, 135.00)j,k,l | 105.00 (87.00, 126.50)j,k,l | 116.00 (97.00, 136.50)j,k,l |
统计量 | 117.122m | 282.263n | 1.100n | 66.400m | 12.372n | 96.118n | 70.413m | 120.459n | 106.438n | 101.474n |
P值 | 0.000 | 0.000 | 0.777 | 0.000 | 0.006 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
[1] |
MacNeil A, Glaziou P, Sismanidis C, et al. Global epidemiology of tuberculosis and progress toward achieving global targets—2017. MMWR Morb Mortal Wkly Rep, 2019,68(11):263-266. doi: 10.15585/mmwr.mm6811a3.
doi: 10.15585/mmwr.mm6811a3 URL pmid: 30897077 |
[2] |
Gupte AN, Paradkar M, Selvaraju S, et al. Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD. PLoS One, 2019,14(5):e0217289. doi: 10.1371/journal.pone.0217289.
doi: 10.1371/journal.pone.0217289 URL pmid: 31120971 |
[3] |
Vashakidze SA, Kempker JA, Jakobia , et al. Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis. Int J Infect Dis, 2019,82:66-72. doi: 10.1016/j.ijid.2019.02.039.
doi: 10.1016/j.ijid.2019.02.039 URL pmid: 30844519 |
[4] | 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第一部分)——概述及一般要求. 中华结核和呼吸杂志, 2014,37(6):402-405. doi: 10.3760/cma.j.issn.1001-0939.2014.06.002. |
[5] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09. |
[6] | 中华医学会,中华医学会杂志社,中华医学会全科医学分会, 等. 肺结核基层诊疗指南(2018年). 中华全科医师杂志, 2019,18(8):709-717. doi: 10.3760/cma.j.issn.1671-7368.2019.08.002. |
[7] | 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第二部分)——肺量计检查. 中华结核和呼吸杂志, 2014,37(7):481-486. doi: 10.3760/cma.j.issn.1001-0939.2014.07.001. |
[8] | 郑劲平. 肺功能学:基础与临床. 广州: 广东科学技术出版社, 2007:61. |
[9] | 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南——肺弥散功能检查. 中华结核和呼吸杂志, 2015,38(3):164-169. doi: 10.3760/cma.j.issn.1001-0939.2015.03.003. |
[10] | 朱蕾. 临床肺功能.2版. 北京: 人民卫生出版社, 2014:420. |
[11] |
Daniels KJ, Irusen E, Pharaoh H, et al. Post-tuberculosis health-related quality of life, lung function and exercise capacity in a cured pulmonary tuberculosis population in the Breede Valley District, South Africa. S Afr J Physiother, 2019,75(1):1319. doi: 10.4102/sajp.v75i1.1319.
URL pmid: 31392293 |
[12] |
Fiogbe AA, Agodokpessi G, Tessier JF, et al. Prevalence of lung function impairment in cured pulmonary tuberculosis patients in Cotonou, Benin. Int J Tuberc Lung Dis, 2019,23(2):195-202. doi: 10.5588/ijtld.18.0234.
doi: 10.5588/ijtld.18.0234 URL pmid: 30808452 |
[13] | Chakaya J, Kirenga B, Getahun H. Long term complications after completion of pulmonary tuberculosis treatment: a quest for a Public Health Approach. J Clin Tuberc Other Mycobact Dis, 2016,3:10-12. doi: 10.1016/j.jctube.2016.03.001. |
[14] |
Amaral AF, Coton S, Kato B, et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J, 2015,46(4):1104-1112. doi: 10.1183/13993003.02325-2014.
doi: 10.1183/13993003.02325-2014 URL pmid: 26113680 |
[15] |
Mohamed M, Shayo G, Mamuya S, et al. Lung functions among patients with pulmonary tuberculosis in Dar es Salaam-a cross-sectional study. BMC Pulm Med, 2016,16(1):58. doi: 10.1186/s12890-016-0213-5.
URL pmid: 27107713 |
[16] | Marcela MT, Adrian R, Rosella C, et al. Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis. J Bras Pneumol, 2016,42(5):374-385. doi: 10.1590/S1806-37562016000000226. |
[17] | de la Mora IL, Martínez Oceguera D, Laniado Laborín R. Chronic airway obstruction after successful treatment of tuberculosis and its impact on quality of life. Int J Tuberc Lung Dis, 2015,19(7):808-810. doi: 10.5588/ijtld.14.0983. |
[18] | Jung JW, Choi JC, Shin JW, et al. Pulmonary impairment in tuberculosis survivors: the Korean National Health and Nutrition Examination Survey 2008-2012. PLoS One, 2015,10(10):e0141230. doi: 10.1371/journal.pone.0141230. |
[1] | DENG Guo-fang, LEI Jian-ping. Analysis on diagnosis and treatment of coronavirus disease 2019(COVID-19) [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 7-10. |
[2] | WU Gui-hui, HUANG Tao. Problems and suggestions in the treatment of TB/HIV coinfection [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(1): 11-16. |
[3] | JING Rui, CAO Yan-min, YANG Yi-jun, WU Hong-yan, CAI Jun-li, REN Wen, ZHANG Wen-qian, WANG Mei-hua. A study of application of electronic pillbox and mobile WeChat APP on pulmonary tuberculosis patient supervision and management of taking medication [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(1): 96-99. |
[4] | Ni WANG,Fei HUANG,Hui ZHANG. Implementation electronic medication monitor in tuberculosis medication management [J]. Journal of Tuberculosis and Lung Health, 2019, 8(4): 244-248. |
[5] | Song YANG,Xiao-feng YAN. Current status and future prospects on the treatment of multi/extensively drug-resistant tuberculosis with bedaquiline [J]. Journal of Tuberculosis and Lung Health, 2019, 8(4): 249-252. |
[6] | MA Jin-bao,MA Ting-ting,REN Fei,YANG Hong.. Analysis of hypokalemia caused by capreomycin in patients with multidrug-resistant tuberculosis [J]. Journal of Tuberculosis and Lung Health, 2019, 8(3): 183-187. |
[7] | Shuang LIANG,Dong-wei HAN,Wei ZHONG,Ning MAO,Yi LIU,Yi-wen JIANG. Analysis of effect of FDC chemethorapy combined with levofloxacin in patients with smear positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Health, 2019, 8(2): 149-152. |
[8] | Wei SHA. Responsibility of doctors from tuberculous hospitals in the diagnosis and treatment of tuberculosis outbreak in school [J]. Journal of Tuberculosis and Lung Health, 2019, 8(2): 83-85. |
[9] | Bao-jiang WEN,Xiao-dong DENG,Guang-yong FENG,Wen-pei. WEN. Analysis on the effectiveness of different tuberculosis prevention and control system models in Guangdong Province [J]. Journal of Tuberculosis and Lung Health, 2019, 8(1): 19-23. |
[10] | Li-hua ZHENG,Jing-lai YU,Peng SUN,Hong-qing LI,Dong CHEN,Ying-jie YU,Sha NI,Ming XU,Yan CHENG,Chun-guang MA,Chun-yu ZHAO,Na YANG,Gui-jiao LI,Juan. LI. Clinical efficacy analysis of Qingfei Qulao Pill in the treatment of patients with relapsed pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Health, 2018, 7(2): 114-119. |
[11] | Su-hua. MENG. Clinical efficacy of local drug administration by bronchfiberscope combined with chemotherapy in the treatment of multi-drug resistant pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Health, 2018, 7(2): 146-148. |
[12] | Zhuang-hao CHEN,Jian-xiong LIN,Dong-dong PENG,Rui-ming CHEN,Xiao-ying CHEN,Wen-pei WEN. The establishment and application evaluation of health management information system for TB patients in Shantou City [J]. Journal of Tuberculosis and Lung Health, 2018, 7(1): 60-63. |
[13] | Jian-ming PENG,Zhi-dong LIU,Qiu ZHONG,Lin-hua LIU,Liang CHEN,Xiao-fen LI,Jian-feng WENG,Bi-wei HUANG,Wen-jie CHEN. Application effects evaluation of WeChat-based multi-functional information system for tuberculosis control and management [J]. Journal of Tuberculosis and Lung Health, 2018, 7(1): 74-76. |
[14] | CHEN Yu,LI Gui-qin. The analysis of diagnosis and treatment on urinary tuberculosis complicated with chronic kidney disease(3 cases report) [J]. Journal of Tuberculosis and Lung Health, 2017, 6(3): 222-228. |
[15] | TANG Shen-jie. Shortening the treatment course of tuberculosis: past, present and future [J]. Journal of Tuberculosis and Lung Health, 2016, 5(1): 19-. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||